|
1
|
Li Y, de Haar C, Chen M, Deuring J,
Gerrits MM, Smits R, Xia B, Kuipers EJ and van der Woude CJ:
Disease-related expression of the IL6/STAT3/SOCS3 signalling
pathway in ulcerative colitis and ulcerative colitis-related
carcinogenesis. Gut. 59:227–235. 2010. View Article : Google Scholar
|
|
2
|
Li Y, Nuij VJ, Baars JE, Biermann K,
Kuipers EJ, Peppelenbosch MP, de Haar C and van der Woude Janneke
C: Increased suppressor of cytokine signaling-3 expression predicts
mucosal relapse in ulcerative colitis. Inflamm Bowel Dis.
19:132–140. 2013. View Article : Google Scholar
|
|
3
|
Li Y, de Haar C, Peppelenbosch MP and van
der Woude CJ: SOCS3 in immune regulation of inflammatory bowel
disease and inflammatory bowel disease-related cancer. Cytokine
Growth Factor Rev. 23:127–138. 2012. View Article : Google Scholar
|
|
4
|
Fang K, Bruce M, Pattillo CB, Zhang S,
Stone R II, Clifford J and Kevil CG: Temporal genomewide expression
profiling of DSS colitis reveals novel inflammatory and
angiogenesis genes similar to ulcerative colitis. Physiol Genomics.
43:43–56. 2011. View Article : Google Scholar
|
|
5
|
Linke A, Goren I, Bösl MR, Pfeilschifter J
and Frank S: Epithelial overexpression of SOCS-3 in transgenic mice
exacerbates wound inflammation in the presence of elevated
TGF-beta1. J Invest Dermatol. 130:866–875. 2010. View Article : Google Scholar
|
|
6
|
Linke A, Goren I, Bosl MR, Pfeilschifter J
and Frank S: The suppressor of cytokine signaling (SOCS)-3
determines keratinocyte proliferative and migratory potential
during skin repair. J Invest Dermatol. 130:876–885. 2010.
View Article : Google Scholar
|
|
7
|
Planell N, Lozano JJ, Mora-Buch R,
Masamunt MC, Jimeno M, Ordás I, Esteller M, Ricart E, Piqué JM,
Panes J and Salas A: Transcriptional analysis of the intestinal
mucosa of patients with ulcerative colitis in remission reveals
lasting epithelial cell alterations. Gut. 62:967–976. 2013.
View Article : Google Scholar
|
|
8
|
Broadhurst MJ, Leung JM, Kashyap V, McCune
JM, Mahadevan U, McKerrow JH and Loke P: IL-22+ CD4+ T cells are
associated with therapeutic Trichuris trichiura infection in
an ulcerative colitis patient. Sci Transl Med. 2:60ra882010.
View Article : Google Scholar
|
|
9
|
Fukui H, Sekikawa A, Tanaka H, Fujimori Y,
Katake Y, Fujii S, Ichikawa K, Tomita S, Imura J, Chiba T and
Fujimori T: DMBT1 is a novel gene induced by IL-22 in ulcerative
colitis. Inflamm Bowel Dis. 17:1177–1188. 2011. View Article : Google Scholar
|
|
10
|
Goldsmith JR, Uronis JM and Jobin C: Mu
opioid signaling protects against acute murine intestinal injury in
a manner involving Stat3 signaling. Am J Pathol. 179:673–683. 2011.
View Article : Google Scholar :
|
|
11
|
Vaishnava S, Yamamoto M, Severson KM, Ruhn
KA, Yu X, Koren O, Ley R, Wakeland EK and Hooper LV: The
antibacterial lectin RegIIIgamma promotes the spatial segregation
of microbiota and host in the intestine. Science. 334:255–258.
2011. View Article : Google Scholar :
|
|
12
|
Mukherjee S, Zheng H, Derebe MG,
Callenberg KM, Partch CL, Rollins D, Propheter DC, Rizo J, Grabe M,
Jiang QX and Hooper LV: Antibacterial membrane attack by a
pore-forming intestinal C-type lectin. Nature. 505:103–107. 2014.
View Article : Google Scholar
|
|
13
|
Murano T, Okamoto R, Ito G, Nakata T,
Hibiya S, Shimizu H, Fujii S, Kano Y, Mizutani T, Yui S, et al:
Hes1 promotes the IL-22-mediated antimicrobial response by
enhancing STAT3-dependent transcription in human intestinal
epithelial cells. Biochem Biophys Res Commun. 443:840–846. 2014.
View Article : Google Scholar
|
|
14
|
Ahmad R, Chaturvedi R, Olivares-Villagómez
D, Habib T, Asim M, Shivesh P, Polk DB, Wilson KT, Washington MK,
Van Kaer L, et al: Targeted colonic claudin-2 expression renders
resistance to epithelial injury, induces immune suppression, and
protects from colitis. Mucosal Immunol. 7:1340–1353. 2014.
View Article : Google Scholar :
|
|
15
|
Bian Z, Li L, Cui J, Zhang H, Liu Y, Zhang
CY and Zen K: Role of miR-150-targeting c-Myb in colonic epithelial
disruption during dextran sulphate sodium-induced murine
experimental colitis and human ulcerative colitis. J Pathol.
225:544–553. 2011. View Article : Google Scholar
|
|
16
|
Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao
Y, Wang X and Sun B: Interleukin-22 promotes human hepatocellular
carcinoma by activation of STAT3. Hepatology. 54:900–909. 2011.
View Article : Google Scholar
|
|
17
|
Dang CV: MYC on the path to cancer. Cell.
149:22–35. 2012. View Article : Google Scholar :
|
|
18
|
Lin CY, Loven J, Rahl PB, Paranal RM,
Burge CB, Bradner JE, Lee TI and Young RA: Transcriptional
amplification in tumor cells with elevated c-Myc. Cell. 151:56–67.
2012. View Article : Google Scholar :
|
|
19
|
Naher L, Kiyoshima T, Kobayashi I, Wada H,
Nagata K, Fujiwara H, Ookuma YF, Ozeki S, Nakamura S and Sakai H:
STAT3 signal transduction through interleukin-22 in oral squamous
cell carcinoma. Int J Oncol. 41:1577–1586. 2012. View Article : Google Scholar :
|
|
20
|
Dunn ET, Taylor ES, Stebbings S, Schultz
M, Butt AG and Kemp RA: Distinct immune signatures in the colon of
Crohn's disease and ankylosing spondylitis patients in the absence
of inflammation. Immunol Cell Biol. 94:421–429. 2016. View Article : Google Scholar
|
